Adverse Experience Reporting for Licensed Biological Products 21 CFR 600

ICR 199503-0910-002

OMB: 0910-0308

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
ICR Details
0910-0308 199503-0910-002
Historical Active
HHS/FDA
Adverse Experience Reporting for Licensed Biological Products 21 CFR 600
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 05/23/1995
Retrieve Notice of Action (NOA) 03/24/1995
  Inventory as of this Action Requested Previously Approved
05/31/1998 05/31/1998
645 0 0
8,329 0 0
0 0 0

This final rule enables FDA to take actions necessary for protection of the public health in response to reports of adverse experience related to licensed biological products.

None
None


No

1
IC Title Form No. Form Name
Adverse Experience Reporting for Licensed Biological Products 21 CFR 600 FDA-3500, FDA-3500A

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 645 0 0 645 0 0
Annual Time Burden (Hours) 8,329 0 0 8,329 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/24/1995


© 2024 OMB.report | Privacy Policy